UPDATE: MLV Initiates Coverage On Tenax Therapeutics

By: via Benzinga
Analysts at MLV & Co on Tuesday initiated coverage of Tenax Therapeutics Inc (NASDAQ: TENX) with a Buy rating and $7 price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.